nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—Antinuclear antibody positive—Ramipril—type 1 diabetes mellitus	0.0523	0.185	CcSEcCtD
Prazosin—MT3—nerve—type 1 diabetes mellitus	0.0355	0.244	CbGeAlD
Prazosin—ORM1—saliva—type 1 diabetes mellitus	0.0201	0.138	CbGeAlD
Prazosin—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0122	0.0429	CcSEcCtD
Prazosin—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.0106	0.0375	CcSEcCtD
Prazosin—KCNH6—nephron tubule—type 1 diabetes mellitus	0.00988	0.0677	CbGeAlD
Prazosin—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00946	0.0334	CcSEcCtD
Prazosin—KCNH6—kidney—type 1 diabetes mellitus	0.00868	0.0595	CbGeAlD
Prazosin—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00787	0.0278	CcSEcCtD
Prazosin—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00786	0.0538	CbGeAlD
Prazosin—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.0073	0.0258	CcSEcCtD
Prazosin—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00726	0.0256	CcSEcCtD
Prazosin—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00726	0.0256	CcSEcCtD
Prazosin—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00714	0.0252	CcSEcCtD
Prazosin—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00686	0.0242	CcSEcCtD
Prazosin—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00627	0.0221	CcSEcCtD
Prazosin—SLC22A2—nephron tubule—type 1 diabetes mellitus	0.00584	0.04	CbGeAlD
Prazosin—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00556	0.0196	CcSEcCtD
Prazosin—Flushing—Ramipril—type 1 diabetes mellitus	0.00553	0.0195	CcSEcCtD
Prazosin—Alopecia—Ramipril—type 1 diabetes mellitus	0.00527	0.0186	CcSEcCtD
Prazosin—SLC22A2—kidney—type 1 diabetes mellitus	0.00514	0.0352	CbGeAlD
Prazosin—Tension—Ramipril—type 1 diabetes mellitus	0.00509	0.018	CcSEcCtD
Prazosin—Nervousness—Ramipril—type 1 diabetes mellitus	0.00504	0.0178	CcSEcCtD
Prazosin—ADRA1B—kidney—type 1 diabetes mellitus	0.00492	0.0337	CbGeAlD
Prazosin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00482	0.017	CcSEcCtD
Prazosin—Malaise—Ramipril—type 1 diabetes mellitus	0.00468	0.0165	CcSEcCtD
Prazosin—Vertigo—Ramipril—type 1 diabetes mellitus	0.00466	0.0165	CcSEcCtD
Prazosin—Syncope—Ramipril—type 1 diabetes mellitus	0.00466	0.0164	CcSEcCtD
Prazosin—Palpitations—Ramipril—type 1 diabetes mellitus	0.00459	0.0162	CcSEcCtD
Prazosin—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00456	0.0161	CcSEcCtD
Prazosin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00442	0.0156	CcSEcCtD
Prazosin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00437	0.0154	CcSEcCtD
Prazosin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00432	0.0153	CcSEcCtD
Prazosin—Oedema—Ramipril—type 1 diabetes mellitus	0.00424	0.015	CcSEcCtD
Prazosin—Shock—Ramipril—type 1 diabetes mellitus	0.00417	0.0147	CcSEcCtD
Prazosin—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00413	0.0146	CcSEcCtD
Prazosin—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.0041	0.0145	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00386	0.0136	CcSEcCtD
Prazosin—Insomnia—Ramipril—type 1 diabetes mellitus	0.00383	0.0135	CcSEcCtD
Prazosin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.0038	0.0134	CcSEcCtD
Prazosin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00378	0.0133	CcSEcCtD
Prazosin—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.00377	0.0258	CbGeAlD
Prazosin—Somnolence—Ramipril—type 1 diabetes mellitus	0.00377	0.0133	CcSEcCtD
Prazosin—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.00367	0.0252	CbGeAlD
Prazosin—Fatigue—Ramipril—type 1 diabetes mellitus	0.00365	0.0129	CcSEcCtD
Prazosin—SLC22A1—kidney—type 1 diabetes mellitus	0.00363	0.0249	CbGeAlD
Prazosin—Constipation—Ramipril—type 1 diabetes mellitus	0.00362	0.0128	CcSEcCtD
Prazosin—HTR1D—kidney—type 1 diabetes mellitus	0.0036	0.0246	CbGeAlD
Prazosin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00349	0.0123	CcSEcCtD
Prazosin—SLC22A3—kidney—type 1 diabetes mellitus	0.00347	0.0238	CbGeAlD
Prazosin—Urticaria—Ramipril—type 1 diabetes mellitus	0.00337	0.0119	CcSEcCtD
Prazosin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00335	0.0118	CcSEcCtD
Prazosin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00312	0.011	CcSEcCtD
Prazosin—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00306	0.021	CbGeAlD
Prazosin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00304	0.0107	CcSEcCtD
Prazosin—Pruritus—Ramipril—type 1 diabetes mellitus	0.003	0.0106	CcSEcCtD
Prazosin—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00297	0.0203	CbGeAlD
Prazosin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.0029	0.0102	CcSEcCtD
Prazosin—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.00282	0.0193	CbGeAlD
Prazosin—Dizziness—Ramipril—type 1 diabetes mellitus	0.0028	0.00989	CcSEcCtD
Prazosin—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.00273	0.0187	CbGeAlD
Prazosin—ABCG2—nephron tubule—type 1 diabetes mellitus	0.0027	0.0185	CbGeAlD
Prazosin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00269	0.00951	CcSEcCtD
Prazosin—Rash—Ramipril—type 1 diabetes mellitus	0.00267	0.00943	CcSEcCtD
Prazosin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00267	0.00942	CcSEcCtD
Prazosin—Headache—Ramipril—type 1 diabetes mellitus	0.00265	0.00937	CcSEcCtD
Prazosin—Nausea—Ramipril—type 1 diabetes mellitus	0.00252	0.00888	CcSEcCtD
Prazosin—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.00237	0.0163	CbGeAlD
Prazosin—CYP1A1—kidney—type 1 diabetes mellitus	0.00225	0.0154	CbGeAlD
Prazosin—ADRA2A—pancreas—type 1 diabetes mellitus	0.00209	0.0143	CbGeAlD
Prazosin—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00165	0.0113	CbGeAlD
Prazosin—ABCB1—retina—type 1 diabetes mellitus	0.00141	0.00969	CbGeAlD
Prazosin—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00133	0.00912	CbGeAlD
Prazosin—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.0012	0.00819	CbGeAlD
Prazosin—ABCB1—kidney—type 1 diabetes mellitus	0.00117	0.00802	CbGeAlD
Prazosin—ABCB1—pancreas—type 1 diabetes mellitus	0.00116	0.00796	CbGeAlD
Prazosin—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.00101	0.00689	CbGeAlD
Prazosin—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	0.000104	0.000182	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000104	0.000181	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	0.000103	0.000181	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—GCG—type 1 diabetes mellitus	0.000103	0.000181	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000102	0.000179	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000101	0.000177	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000101	0.000176	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.0001	0.000176	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.0001	0.000175	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.95e-05	0.000174	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—GCG—type 1 diabetes mellitus	9.94e-05	0.000174	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	9.89e-05	0.000173	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	9.87e-05	0.000173	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.86e-05	0.000173	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.83e-05	0.000172	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.73e-05	0.00017	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	9.71e-05	0.00017	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.67e-05	0.000169	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	9.67e-05	0.000169	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ITPR3—type 1 diabetes mellitus	9.63e-05	0.000169	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—GCG—type 1 diabetes mellitus	9.6e-05	0.000168	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.56e-05	0.000168	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CD86—type 1 diabetes mellitus	9.46e-05	0.000166	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	9.42e-05	0.000165	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	9.36e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	9.36e-05	0.000164	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	9.3e-05	0.000163	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.29e-05	0.000163	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.26e-05	0.000162	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SST—type 1 diabetes mellitus	9.25e-05	0.000162	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—INS—type 1 diabetes mellitus	9.23e-05	0.000162	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.21e-05	0.000161	CbGpPWpGaD
Prazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	9.21e-05	0.000161	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	9.17e-05	0.000161	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	9.11e-05	0.00016	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—HBA1—type 1 diabetes mellitus	9.06e-05	0.000159	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.04e-05	0.000158	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	9.04e-05	0.000158	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOC3—type 1 diabetes mellitus	9e-05	0.000158	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.98e-05	0.000157	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GCG—type 1 diabetes mellitus	8.97e-05	0.000157	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	8.96e-05	0.000157	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GSTT1—type 1 diabetes mellitus	8.84e-05	0.000155	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	8.83e-05	0.000155	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	8.81e-05	0.000154	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	8.75e-05	0.000153	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CAT—type 1 diabetes mellitus	8.72e-05	0.000153	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	8.7e-05	0.000152	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	8.7e-05	0.000152	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	8.66e-05	0.000152	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.63e-05	0.000151	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.53e-05	0.00015	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—ALB—type 1 diabetes mellitus	8.46e-05	0.000148	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.44e-05	0.000148	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.41e-05	0.000147	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.39e-05	0.000147	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.39e-05	0.000147	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	8.39e-05	0.000147	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.36e-05	0.000147	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.33e-05	0.000146	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	8.33e-05	0.000146	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.27e-05	0.000145	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GCG—type 1 diabetes mellitus	8.25e-05	0.000144	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	8.22e-05	0.000144	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	8.21e-05	0.000144	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.21e-05	0.000144	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	8.18e-05	0.000143	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	8.15e-05	0.000143	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	8.14e-05	0.000143	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CAT—type 1 diabetes mellitus	8.13e-05	0.000142	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CD86—type 1 diabetes mellitus	8.1e-05	0.000142	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.09e-05	0.000142	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—NOS3—type 1 diabetes mellitus	8.09e-05	0.000142	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.07e-05	0.000141	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.94e-05	0.000139	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.74e-05	0.000136	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.71e-05	0.000135	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	7.69e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.69e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.69e-05	0.000135	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	7.64e-05	0.000134	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.62e-05	0.000134	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.6e-05	0.000133	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.59e-05	0.000133	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.36e-05	0.000129	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.33e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	7.32e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	7.31e-05	0.000128	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.3e-05	0.000128	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.24e-05	0.000127	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.19e-05	0.000126	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.18e-05	0.000126	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.08e-05	0.000124	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.06e-05	0.000124	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	7.06e-05	0.000124	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.05e-05	0.000124	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	7.05e-05	0.000123	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.03e-05	0.000123	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.01e-05	0.000123	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.98e-05	0.000122	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.98e-05	0.000122	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.94e-05	0.000122	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CD80—type 1 diabetes mellitus	6.9e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	6.89e-05	0.000121	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.85e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.83e-05	0.00012	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	6.81e-05	0.000119	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.74e-05	0.000118	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	6.72e-05	0.000118	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.7e-05	0.000117	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.59e-05	0.000116	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.55e-05	0.000115	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—INS—type 1 diabetes mellitus	6.52e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.48e-05	0.000114	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.42e-05	0.000113	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.39e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.38e-05	0.000112	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.37e-05	0.000112	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.36e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.34e-05	0.000111	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.34e-05	0.000111	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.31e-05	0.000111	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.28e-05	0.00011	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.26e-05	0.00011	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.22e-05	0.000109	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.2e-05	0.000109	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.19e-05	0.000108	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.17e-05	0.000108	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.12e-05	0.000107	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.06e-05	0.000106	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	5.97e-05	0.000105	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	5.96e-05	0.000105	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.96e-05	0.000104	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CD80—type 1 diabetes mellitus	5.91e-05	0.000104	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.88e-05	0.000103	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—INS—type 1 diabetes mellitus	5.85e-05	0.000102	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.83e-05	0.000102	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.83e-05	0.000102	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—INS—type 1 diabetes mellitus	5.79e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	5.78e-05	0.000101	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.76e-05	0.000101	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.72e-05	0.0001	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.7e-05	9.99e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.67e-05	9.93e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.63e-05	9.86e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	5.58e-05	9.78e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	5.55e-05	9.72e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.4e-05	9.46e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—INS—type 1 diabetes mellitus	5.4e-05	9.45e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.38e-05	9.43e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.37e-05	9.41e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	5.36e-05	9.4e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	5.33e-05	9.35e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—ALB—type 1 diabetes mellitus	5.31e-05	9.3e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.3e-05	9.29e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.3e-05	9.28e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.26e-05	9.22e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.22e-05	9.14e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.18e-05	9.08e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.15e-05	9.02e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	5.13e-05	8.99e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—NOS3—type 1 diabetes mellitus	5.08e-05	8.89e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	5.04e-05	8.83e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5e-05	8.77e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.99e-05	8.74e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—type 1 diabetes mellitus	4.95e-05	8.67e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.92e-05	8.62e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	4.9e-05	8.59e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.9e-05	8.58e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.88e-05	8.54e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.87e-05	8.53e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.86e-05	8.51e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.85e-05	8.5e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.85e-05	8.5e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	4.85e-05	8.5e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.82e-05	8.45e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.81e-05	8.43e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.76e-05	8.35e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—NOS3—type 1 diabetes mellitus	4.73e-05	8.29e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.71e-05	8.25e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.68e-05	8.21e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	4.63e-05	8.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	4.57e-05	8.01e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.5e-05	7.89e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.48e-05	7.85e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.46e-05	7.81e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.42e-05	7.74e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.36e-05	7.63e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.35e-05	7.62e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.27e-05	7.48e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	4.19e-05	7.35e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.16e-05	7.28e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	4.15e-05	7.27e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.14e-05	7.25e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.13e-05	7.24e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.12e-05	7.21e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.08e-05	7.15e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.06e-05	7.12e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.05e-05	7.09e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	4.01e-05	7.03e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.98e-05	6.98e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.96e-05	6.94e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	3.96e-05	6.94e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	3.82e-05	6.7e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.75e-05	6.58e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.75e-05	6.57e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.73e-05	6.53e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.71e-05	6.5e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.7e-05	6.48e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.68e-05	6.45e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.68e-05	6.44e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	3.63e-05	6.36e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.62e-05	6.35e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.62e-05	6.34e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.61e-05	6.32e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.6e-05	6.31e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.49e-05	6.12e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	3.47e-05	6.08e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.45e-05	6.04e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.44e-05	6.04e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.43e-05	6.01e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.42e-05	5.99e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.35e-05	5.88e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.17e-05	5.56e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.16e-05	5.54e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.15e-05	5.52e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.06e-05	5.37e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.06e-05	5.36e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.04e-05	5.33e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.04e-05	5.33e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.9e-05	5.08e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.9e-05	5.08e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.87e-05	5.02e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	2.85e-05	4.99e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.85e-05	4.99e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.84e-05	4.98e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.83e-05	4.96e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.77e-05	4.86e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.77e-05	4.85e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.63e-05	4.62e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.57e-05	4.51e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	2.44e-05	4.27e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.39e-05	4.19e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.34e-05	4.1e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.2e-05	3.86e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.17e-05	3.81e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.13e-05	3.73e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.02e-05	3.55e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.8e-05	3.15e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.67e-05	2.93e-05	CbGpPWpGaD
